Lung Stent Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
The demand for lung stents is expected to exceed over the coming years on account of growing prevalence of lung cancer cases worldwide. Rise in number of patient suffering from respiratory disorders caused due to lung cancer might fuel the need for minimally invasive surgeries. These surgeries help patients avoid incisions or pain and heavily rely on stents for effective treatment.
Increasing consumer inclination towards minimally invasive surgeries could massively benefit the business outlook. GMI, estimates that the lung stent market might surpass USD 348 million by the year 2026. Minimally invasive surgeries are gaining popularity among patients suffering from congenital cystic adenomatoid malformations.
Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/4873
The complexity of these respiratory disorders and substantial investments has encouraged the modification of non-vascular stent. For example, the FDA in the United States has recently approved the use of a 3D printed lung stent that has been developed compatible with the patient’s airway. With the extensive inflow of funds mainly to upgrade R&D activities, the introduction of numerous radioactive stent and the biodegradable stent is in-line to facilitate patients.
The laryngeal stent segment accounted for a significant revenue share at US$6 million in 2019. The increased utilization of laryngeal stent to broaden the airway post-surgical reconstruction will lead to considerable segment growth. The product is also used to maintain lumen in the management of laryngeal trauma or cancer resection.
The laryngeal stent also helps in treating a laryngeal fracture, subglottic stenosis, and laryngeal stenosis and is highly effective in the treatment of severe respiratory disorders related to the larynx. The widespread applications of the product in treating numerous medical conditions will foster segment expansion.
A high preference for minimally invasive surgeries to treat respiratory diseases would spur lung stent business growth in the coming years. The increased number of respiratory disorders associated with lung cancer has influenced the high adoption of minimally invasive surgeries among patients in a view to eliminating pain and incision caused during conventional surgeries.
Lung stent market share from the adult patient segment is estimated to grow at 14.7% CAGR in the upcoming years. There escalating prevalence of COPD in a large pool of adult patients due to smoking habits. Unhealthy lifestyles and stress cause high adoption of smoking habits among the adult population. As per the National Center for Biotechnology Information (NCBI), the prevalence of COPD in working adults aged between 40 to 70 years is estimated at around 4%.
The self-expandable lung stent segment is projected to grow at 14.7% CAGR up to 2026. These self-expandable stents are highly preferred in the management of post-intubation tracheal stenosis, benign tracheal stenosis, and central airway obstruction.
The self-expandable lung stents are safe and effectively utilized in the treatment of numerous respiratory disorders such as non-small cell lung cancer and dyspnea. Also, these stents are also used post-lung placement procedures to provide extended support to the patients.
Brazil, with an annual valuation of more than US$2 million dominated the Latin America lung stent industry in 2019. The growing number of patients affected by airway complications will augment regional industry expansion. The burning of sugarcane leaves on a large scale in the country could be one of the prime reasons propelling a high number of respiratory disorders, resulting in rising demand for lung stent placement.
Reportedly, nearly 40% of the Brazilian population are getting benefits from healthcare programs funded by private and public organizations. This has led to high demand for stent placement procedures in the nation. The presence of several initiatives undertaken by the government in a bid to simplify the regulations and supply of lung benefiting COPD patients could lead to regional business growth in the forthcoming years.
Prominent companies in the global lung stent industry include Stening SRL, Novatech SA, Micro-Tech (Nanjing) Co., Ltd., Merit Medical Systems, Inc., Boston Medical Products, Inc., EFER ENDOSCOPY, Cook Group, Hood laboratories, and Boston Scientific Corporation, among others.
Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/lung-stent-market
Partial Chapter of the Table of Content
Chapter 4 Lung Stent Market, By Product
4.1 Key segment trends
4.2 Tracheal stents
4.2.1 Market size, by region, 2015– 2026 (USD Million)
4.3 Bronchial stents
4.3.1 Market size, by region, 2015 – 2026 (USD Million)
4.4 Laryngeal stents
4.4.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 5 Lung Stent Market, By Device Type
5.1 Key segment trends
5.2.1 Market size, by region, 2015 – 2026 (USD Million)
5.3.1 Market size, by region, 2015 – 2026 (USD Million)